Virginia Judge Strikes Down Biden Mifepristone Rule

A Virginia federal judge, U.S. District Judge Robert Ballou, ruled that the Biden administration's rule requiring doctors and pharmacies to obtain special certification to prescribe mifepristone was not adequately justified and must be reevaluated. The court ordered the FDA to reassess the licensing requirements as part of its ongoing review of mifepristone's safety. The decision aligns with a broader set of legal challenges to abortion-related regulations and reflects ongoing tensions between regulatory oversight and reproductive rights. Attorneys for abortion providers argued the licensing rule imposed burdens without sufficient evidence of need, while the ruling signals potential changes in how abortion medications are accessed and dispensed. The case comes amid intensified political and legal battles over reproductive health policies during the Biden presidency, with Republicans seeking to curb mifepristone access in several states. The rulings across multiple articles underscore the judiciary's pivotal role in shaping the implementation of federal abortion-drug regulations.